If you have any question, please feel free to email us. We will touch with you as soon as possible.
Patients with mantle cell lymphoma (MCL) who have received at least one prior treatment. For R&D purposes only.
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Generic name | Ibrutinib Capsules |
Trade name | IMBRUVICA |
Specification | 140mg |
Main ingredients | Ibrutinib |
Appearance | White opaque hard gelatin capsule No. 0 printed in black ink with the words "ibr140mg", the contents of which are white or white like powder. |
MA Holder | Janssen-Cilag International NV |
Manufacturer | Catalent CTS LLC |
Product Type | Reference Listed Drugs (RLDs) |
Indications:
1. Patients with mantle cell lymphoma (MCL) who have received at least one prior treatment;
2. Treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) patients;
3. Patients with Fahrenheit macroglobulinemia should be treated according to the drug label.
For more details,pls contact Janney:
Email: tosun-global@upharm.cn
Wechat/Whatsapp:(+86)18922120575
Hot Tags: IMBRUVICA 140mg Ibrutinib Capsules Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Alfacalcidol Soft Capsules, Adefovir Dipivoxil Tablets, Phenytoin Sodium Tablets, Argatroban Injection, Acarbose Tablets, Agomelatine Tablets
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China